VARIANTS OF DR3 AND USE THEREOF

Amir Aharoni; Itay Levin

VARIANTS OF DR3 AND USE THEREOF

Amir Aharoni (Inventor), Itay Levin (Inventor)

Research output: Patent

Abstract

Death-domain receptor 3 (DR3) variants having increased binding affinity to TL1A, and composition comprising same, are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.

Original language	English
Patent number	US2017114118
IPC	C07K 14/ 705 A I
Priority date	27/04/15
State	Published - 27 Apr 2017

Cite this

@misc{5d9d2e9b06ba4726afc81ea5c05b16db,

title = "VARIANTS OF DR3 AND USE THEREOF",

abstract = "Death-domain receptor 3 (DR3) variants having increased binding affinity to TL1A, and composition comprising same, are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.",

author = "Amir Aharoni and Itay Levin",

year = "2017",

month = apr,

day = "27",

language = "English",

type = "Patent",

note = "US2017114118; C07K 14/ 705 A I",

}

TY - PAT

T1 - VARIANTS OF DR3 AND USE THEREOF

AU - Aharoni, Amir

AU - Levin, Itay

PY - 2017/4/27

Y1 - 2017/4/27

N2 - Death-domain receptor 3 (DR3) variants having increased binding affinity to TL1A, and composition comprising same, are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.

AB - Death-domain receptor 3 (DR3) variants having increased binding affinity to TL1A, and composition comprising same, are provided. Further, methods of use of said peptides or composition, including, but not limited to treatment of autoimmune and/or inflammatory disease are provided.

M3 - Patent

M1 - US2017114118

ER -

VARIANTS OF DR3 AND USE THEREOF

Abstract

Fingerprint

Cite this